NEUBASE THERAPEUTICS INC's ticker is NBSE and the CUSIP is 64132K102. A total of 52 filers reported holding NEUBASE THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $102,000 | -89.3% | 259,441 | -71.4% | 0.03% | -91.1% |
| Q2 2022 | $952,000 | -44.1% | 906,445 | 0.0% | 0.36% | -36.5% |
| Q1 2022 | $1,704,000 | -33.1% | 906,445 | 0.0% | 0.56% | -26.6% |
| Q4 2021 | $2,547,000 | -22.2% | 906,445 | 0.0% | 0.77% | -26.4% |
| Q3 2021 | $3,272,000 | -21.4% | 906,445 | +4.3% | 1.04% | +0.9% |
| Q2 2021 | $4,161,000 | +43.0% | 868,699 | +120.7% | 1.03% | +75.3% |
| Q1 2021 | $2,909,000 | +41.7% | 393,699 | +34.0% | 0.59% | +40.5% |
| Q4 2020 | $2,053,000 | -11.1% | 293,699 | -3.5% | 0.42% | -8.1% |
| Q3 2020 | $2,310,000 | +46.7% | 304,376 | +69.7% | 0.46% | -0.7% |
| Q2 2020 | $1,575,000 | – | 179,404 | – | 0.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 470,524 | $494,000 | 0.50% |
| CARNEGIE MELLON UNIVERSITY | 939,412 | $986,000 | 0.50% |
| CM Management, LLC | 370,000 | $389,000 | 0.41% |
| Decheng Capital Management III (Cayman), LLC | 1,000,000 | $1,050,000 | 0.40% |
| Sio Capital Management, LLC | 906,445 | $952,000 | 0.36% |
| AIGH Capital Management LLC | 1,027,585 | $1,079,000 | 0.28% |
| Greenlight Capital | 2,727,027 | $2,863,000 | 0.22% |
| Worth Venture Partners, LLC | 256,553 | $249,000 | 0.15% |
| PERKINS CAPITAL MANAGEMENT INC | 81,500 | $86,000 | 0.09% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 311,000 | $327,000 | 0.01% |